What is Nutriband Inc?
develops a portfolio of transdermal pharmaceutical products in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 74.15M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.